US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Rain Oncology Inc (RAIN)
Rain Oncology Inc (RAIN) ニュース

RAIN

Rain Oncology (RAIN)

Rain Oncology Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:RAIN

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/02/05	20 : 41	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	NASDAQ:RAIN	Rain Oncology Inc
2024/01/31	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:RAIN	Rain Oncology Inc
2024/01/27	06 : 58	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:RAIN	Rain Oncology Inc
2024/01/27	06 : 56	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:RAIN	Rain Oncology Inc
2024/01/27	06 : 55	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:RAIN	Rain Oncology Inc
2024/01/27	06 : 50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RAIN	Rain Oncology Inc
2024/01/27	06 : 44	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RAIN	Rain Oncology Inc
2024/01/27	06 : 38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RAIN	Rain Oncology Inc
2024/01/27	06 : 36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RAIN	Rain Oncology Inc
2024/01/27	06 : 34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RAIN	Rain Oncology Inc
2024/01/27	06 : 32	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:RAIN	Rain Oncology Inc
2024/01/26	23 : 26	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RAIN	Rain Oncology Inc
2024/01/26	23 : 19	Edgar (US Regulatory)	Form SC 14D9/A - Solicitation, recommendation statements: [Amend]	NASDAQ:RAIN	Rain Oncology Inc
2024/01/26	23 : 13	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	NASDAQ:RAIN	Rain Oncology Inc
2024/01/23	06 : 15	Edgar (US Regulatory)	Form SC 14D9/A - Solicitation, recommendation statements: [Amend]	NASDAQ:RAIN	Rain Oncology Inc
2024/01/19	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RAIN	Rain Oncology Inc
2024/01/17	07 : 22	Edgar (US Regulatory)	Form SC 14D9/A - Solicitation, recommendation statements: [Amend]	NASDAQ:RAIN	Rain Oncology Inc
2024/01/17	07 : 18	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	NASDAQ:RAIN	Rain Oncology Inc
2024/01/04	04 : 57	PR Newswire (US)	Kuehn Law Encourages EGLE, ICVX, RAIN, and AYX Investors to Contact Law Firm	NASDAQ:RAIN	Rain Oncology Inc
2023/12/29	10 : 48	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	NASDAQ:RAIN	Rain Oncology Inc
2023/12/27	23 : 27	Edgar (US Regulatory)	Form SC 14D9 - Solicitation, recommendation statements	NASDAQ:RAIN	Rain Oncology Inc
2023/12/27	23 : 20	Edgar (US Regulatory)	Form SC TO-T - Tender offer statement by Third Party	NASDAQ:RAIN	Rain Oncology Inc
2023/12/14	20 : 06	Edgar (US Regulatory)	Form SC 14D9 - Solicitation, recommendation statements	NASDAQ:RAIN	Rain Oncology Inc
2023/12/14	20 : 06	Edgar (US Regulatory)	Form SC TO-C - Written communication relating to an issuer or third party	NASDAQ:RAIN	Rain Oncology Inc
2023/12/14	20 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RAIN	Rain Oncology Inc
2023/11/10	06 : 05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:RAIN	Rain Oncology Inc
2023/11/10	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RAIN	Rain Oncology Inc
2023/09/12	18 : 45	PR Newswire (US)	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 - (NASDAQ: RAIN)	NASDAQ:RAIN	Rain Oncology Inc
2023/09/06	18 : 45	PR Newswire (US)	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 - (NASDAQ: RAIN)	NASDAQ:RAIN	Rain Oncology Inc
2023/08/29	18 : 45	PR Newswire (US)	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 - (NASDAQ: RAIN)	NASDAQ:RAIN	Rain Oncology Inc

Showing the most relevant articles for your search:NASDAQ:RAIN

1 2 3 4 5 次へ >>

Societe Generale Effekten

Rockridge Capital Corp.

Citigroup Global Markets...

Intesa Sanpaolo

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約